Recently, the High-tech Enterprise Certification Management Work Network announced the first batch of high-tech enterprises that have been recognized in Tianjin for the year 2024. Laviana Pharma (Tianjin) Co., Ltd. successfully passed this high-tech enterprise re-examination, and after initially receiving the title of "National High-tech Enterprise" in 2018, Laviana Pharma has now been certified as a "High-tech Enterprise" for the third time.

Recently, Laviana Pharma (Cangzhou) Co., Ltd. welcomed a delegation of academic staff and students from the School of Energy and Chemical Engineering at Tianjin Ren'ai College. This exchange activity aims to deepen the cooperation between both parties in academic research and talent cultivation, and to promote the enhancement of students' practical skills and career development guidance.

Recently, the first mini marathon race of the 2024 Cangzhou Lingang Economic and Technological Development Zone was grandly held. The event was organized by the Management Committee of Cangzhou Lingang Economic and Technological Development Zone and hosted by the General Union of Cangzhou Lingang Economic and Technological Development Zone, attracting the enthusiastic participation of over 700 employees, family members, and students from local universities. Laviana Pharma actively responded by organizing multiple employees to participate in this mini marathon event, which fully showcased the employees' good physical fitness, positive spirit, and spirit of striving for the best, as well as the vibrant corporate culture.

Recently, an important milestone was reached at the Laviana Pharma Cangzhou GMP production base as the high-efficiency production line officially entered the production workshop and is now in operation. This move signifies another step forward for Laviana Pharma in production efficiency and product quality, injecting strong momentum into the company's long-term development.

The 2024 CPHI Worldwide, the world pharmaceutical raw materials exhibition, was held at FieraMilano in Milan, Italy from October 8th to 10th, 2024. Laviana Pharma showcased its one-stop CDMO professional services at this grand event, gathering more than 2.400 exhibitors from over 160 countries and 60.000 industry professionals from home and abroad to discuss cooperation, innovative research and development, and green, low-carbon sustainable development.

Recently, the BIONNOVA2024 Beijing Innovation Forum was successfully held in Beijing. This grand event brought together numerous elite professionals, academic authorities, and entrepreneurs in the pharmaceutical industry, showcasing the latest research achievements and market dynamics in the field of medicine. It also provided a platform for in-depth communication and collaboration among various parties. As a representative of a technology-driven Contract Development and Manufacturing Organization (CDMO) in the pharmaceutical industry, Laviana Pharma appeared at the conference with its research and business teams.